Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung
- PMID: 20161759
- PMCID: PMC2817751
- DOI: 10.1371/journal.pone.0009112
Sex determining region Y-Box 2 (SOX2) is a potential cell-lineage gene highly expressed in the pathogenesis of squamous cell carcinomas of the lung
Abstract
Background: Non-small cell lung cancer (NSCLC) represents the majority (85%) of lung cancers and is comprised mainly of adenocarcinomas and squamous cell carcinomas (SCCs). The sequential pathogenesis of lung adenocarcinomas and SCCs occurs through dissimilar phases as the former tumors typically arise in the lung periphery whereas the latter normally arise near the central airway.
Methodology/principal findings: We assessed the expression of SOX2, an embryonic stem cell transcriptional factor that also plays important roles in the proliferation of basal tracheal cells and whose expression is restricted to the main and central airways and bronchioles of the developing and adult mouse lung, in NSCLC by various methodologies. Here, we found that SOX2 mRNA levels, from various published datasets, were significantly elevated in lung SCCs compared to adenocarcinomas (all p<0.001). Moreover, a previously characterized OCT4/SOX2/NANOG signature effectively separated lung SCCs from adenocarcinomas in two independent publicly available datasets which correlated with increased SOX2 mRNA in SCCs. Immunohistochemical analysis of various histological lung tissue specimens demonstrated marked nuclear SOX2 protein expression in all normal bronchial epithelia, alveolar bronchiolization structures and premalignant lesions in SCC development (hyperplasia, dysplasia and carcinoma in situ) and absence of expression in all normal alveoli and atypical adenomatous hyperplasias. Moreover, SOX2 protein expression was greatly higher in lung SCCs compared to adenocarcinomas following analyses in two independent large TMA sets (TMA set I, n = 287; TMA set II, n = 511 both p<0.001). Furthermore, amplification of SOX2 DNA was detected in 20% of lung SCCs tested (n = 40) and in none of the adenocarcinomas (n = 17).
Conclusions/significance: Our findings highlight a cell-lineage gene expression pattern for the stem cell transcriptional factor SOX2 in the pathogenesis of lung SCCs and suggest a differential activation of stem cell-related pathways between squamous cell carcinomas and adenocarcinomas of the lung.
Conflict of interest statement
Figures
Similar articles
-
Putative stemness markers octamer-binding transcription factor 4, sex-determining region Y-box 2, and NANOG in non-small cell lung carcinoma: A clinicopathological association.J Cancer Res Ther. 2020 Jul-Sep;16(4):804-810. doi: 10.4103/jcrt.JCRT_213_18. J Cancer Res Ther. 2020. PMID: 32930122
-
Morphologic and clinicopathologic features of lung squamous cell carcinomas expressing Sox2.Am J Clin Pathol. 2012 Nov;138(5):712-8. doi: 10.1309/AJCP05TTWQTWNLTN. Am J Clin Pathol. 2012. PMID: 23086772
-
Hyaluronan-CD44v3 interaction with Oct4-Sox2-Nanog promotes miR-302 expression leading to self-renewal, clonal formation, and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma.J Biol Chem. 2012 Sep 21;287(39):32800-24. doi: 10.1074/jbc.M111.308528. Epub 2012 Jul 30. J Biol Chem. 2012. PMID: 22847005 Free PMC article.
-
Sox2/Oct4: A delicately balanced partnership in pluripotent stem cells and embryogenesis.Biochim Biophys Acta. 2016 Jun;1859(6):780-91. doi: 10.1016/j.bbagrm.2016.03.006. Epub 2016 Mar 23. Biochim Biophys Acta. 2016. PMID: 26992828 Review.
-
Are adenosquamous lung carcinomas a simple mix of adenocarcinomas and squamous cell carcinomas, or more complex at the molecular level?Lung Cancer. 2010 Apr;68(1):1-9. doi: 10.1016/j.lungcan.2009.11.001. Epub 2009 Dec 8. Lung Cancer. 2010. PMID: 20004040 Review.
Cited by
-
Evidence that SOX2 overexpression is oncogenic in the lung.PLoS One. 2010 Jun 10;5(6):e11022. doi: 10.1371/journal.pone.0011022. PLoS One. 2010. PMID: 20548776 Free PMC article.
-
LMO1 is a novel oncogene in lung cancer, and its overexpression is a new predictive marker for anti-EGFR therapy.Med Oncol. 2014 Aug;31(8):99. doi: 10.1007/s12032-014-0099-0. Epub 2014 Jul 19. Med Oncol. 2014. PMID: 25037573
-
Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.Int J Med Sci. 2018 Feb 5;15(4):339-351. doi: 10.7150/ijms.22927. eCollection 2018. Int J Med Sci. 2018. PMID: 29511369 Free PMC article.
-
Development of Kras mutant lung adenocarcinoma in mice with knockout of the airway lineage-specific gene Gprc5a.Int J Cancer. 2017 Oct 15;141(8):1589-1599. doi: 10.1002/ijc.30851. Epub 2017 Jul 17. Int J Cancer. 2017. PMID: 28653505 Free PMC article.
-
CXCR2 expression in tumor cells is a poor prognostic factor and promotes invasion and metastasis in lung adenocarcinoma.Cancer Res. 2013 Jan 15;73(2):571-82. doi: 10.1158/0008-5472.CAN-12-0263. Epub 2012 Nov 30. Cancer Res. 2013. PMID: 23204236 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials